Human Cancer Therapy Using Engineered Matrix Metalloproteinase-Activated Anthrax Lethal Toxin That Target Tumor Vasculature

Technology
E-070-2007
Patent ID
E-070-2007-2-US-02
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
 
Publication Number
US-2010-0168012
Application Number
12/519,362
IC
NIAID
Date Filed
Date Issued
 
Patent PDF